Progression of atypical parkinsonian syndromes: prospect-m-uk study implications for clinical trials

HIGHLIGHTS

• who: rdserver1 from the related disorders, to compare candidate clinical trial endpointsIn this multicentre United Kingdom , University of Cambridge Department of Clinical Neurosciences and Cambridge University have published the research work: Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials, in the Journal: Neurology, London, UK
• what: The authors report the longitudinal PROSPECT-M- UK study of progressive supranuclear palsy corticobasal multiple system atrophy and related disorders to compare candidate clinical trial endpoints.
• how: The authors calculated annual rate of change with linear mixed modelling and sample sizes for . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.